Noncoding RNAs in Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Wiley Interdisciplinary Reviews - RNA

• Publication date

  2018-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/wrna.1463PMID 29327503PMCID PMC5847280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapid amyloid‐β oligomer and protofibril accumulation in traumatic brain injury

  2018cited by this paper
• Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.

  2018cited by this paper
• APP as a Protective Factor in Acute Neuronal Insults

  2017cited by this paper
• APP mouse models for Alzheimer's disease preclinical studies

  2017cited by this paper
• miR‐34a knockout attenuates cognitive deficits in APP/PS1 mice through inhibition of the amyloidogenic processing of APP

  2017cited by this paper
• Small RNA sequencing revealed dysregulated piRNAs in Alzheimer's disease and their probable role in pathogenesis.

  2017cited by this paper
• Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.

  2017cited by this paper
• Brain metabolism in health, aging, and neurodegeneration

  2017cited by this paper
• Senescence-Associated MicroRNAs.

  2017cited by this paper
• Long Noncoding RNAs and RNA-Binding Proteins in Oxidative Stress, Cellular Senescence, and Age-Related Diseases

  2017cited by this paper
• Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1

  2017cited by this paper
• Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

  2017cited by this paper
• Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA

  2017cited by this paper
• Cellular cholesterol homeostasis and Alzheimer’s disease

  2017cited by this paper
• Amyloid‐β and islet amyloid pathologies link Alzheimer’s disease and type 2 diabetes in a transgenic model

  2017cited by this paper
• ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease.

  2017cited by this paper
• Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction

  2017cited by this paper
• PIWI family emerging as a decisive factor of cell fate: An overview.

  2017influential reference
• Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression

  2017cited by this paper
• The circular RNA ciRS‐7 promotes APP and BACE1 degradation in an NF‐κB‐dependent manner

  2017cited by this paper
• Silencing Of Circular RNA-ZNF609 Ameliorates Vascular Endothelial Dysfunction

  2017cited by this paper
• Translation of CircRNAs

  2017cited by this paper
• Extensive translation of circular RNAs driven by N6-methyladenosine

  2017cited by this paper
• Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis

  2017cited by this paper
• Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.

  2017cited by this paper
• Long noncoding RNAs: lincs between human health and disease.

  2017cited by this paper
• Circular RNA Related to the Chondrocyte ECM Regulates MMP13 Expression by Functioning as a MiR-136 ‘Sponge’ in Human Cartilage Degradation

  2016cited by this paper
• Circular RNAs are miRNA sponges and can be used as a new class of biomarker.

  2016cited by this paper
• miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.

  2016cited by this paper
• A novel approach for multi-SNP GWAS and its application in Alzheimer’s disease

  2016cited by this paper
• Long Noncoding RNAs in Cancer Pathways.

  2016cited by this paper
• Circular RNAs: analysis, expression and potential functions

  2016cited by this paper
• Recombinant pre-miR-29b for Alzheimer´s disease therapeutics

  2016cited by this paper
• Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease

  2016cited by this paper
• Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.

  2016cited by this paper
• MicroRNA-155 deletion reduces anxiety- and depressive-like behaviors in mice.

  2016cited by this paper
• Long non-coding RNAs: Mechanism of action and functional utility

  2016influential reference
• The Role of Long Noncoding RNAs in Neurodegenerative Diseases

  2016cited by this paper
• The biogenesis and emerging roles of circular RNAs

  2016cited by this paper
• Alzheimer’s disease: presence and role of microRNAs

  2016cited by this paper
• Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer’s Disease (AD) is Linked to Deficits in a Natural Circular miRNA-7 Sponge (circRNA; ciRS-7)

  2016cited by this paper
• miR‐186 is decreased in aged brain and suppresses BACE1 expression

  2016cited by this paper
• Re-evaluation of the roles of DROSHA, Exportin 5, and DICER in microRNA biogenesis

  2016cited by this paper
• Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities

  2016cited by this paper
• Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease.

  2015cited by this paper
• microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain

  2015cited by this paper
• Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases

  2015cited by this paper
• Small molecule chemical probes of microRNA function.

  2015cited by this paper
• Circular RNA: A new star of noncoding RNAs.

  2015cited by this paper
• Gene expression regulation: lessons from noncoding RNAs

  2015cited by this paper
• Transcriptomics Profiling of Alzheimer’s Disease Reveal Neurovascular Defects, Altered Amyloid-β Homeostasis, and Deregulated Expression of Long Noncoding RNAs

  2015cited by this paper
• Identification of Alzheimer's disease-associated long noncoding RNAs.

  2015cited by this paper
• Direct intracerebral delivery of a miR-33 antisense oligonucleotide into mouse brain increases brain ABCA1 expression. [Corrected].

  2015cited by this paper
• Noncoding RNA in age-related cardiovascular diseases

  2015cited by this paper
• miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.

  2015cited by this paper
• MicroRNAs in apoptosis, autophagy and necroptosis

  2015cited by this paper
• The emerging role of microRNAs in Alzheimer's disease

  2015cited by this paper
• MicroRNA-195 protects against dementia induced by chronic brain hypoperfusion and its relation to APLP2

  2015cited by this paper
• Dynamic expression of long noncoding RNAs and repeat elements in synaptic plasticity

  2015cited by this paper
• MicroRNA‐138 promotes tau phosphorylation by targeting retinoic acid receptor alpha

  2015cited by this paper
• MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo.

  2015cited by this paper
• Efficient backsplicing produces translatable circular mRNAs

  2015cited by this paper
• The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain.

  2015cited by this paper
• Antisense RNA controls LRP1 Sense transcript expression through interaction with a chromatin-associated protein, HMGB2.

  2015cited by this paper
• MicroRNA-29 c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo

  2015cited by this paper
• MiR-16 regulates cell death in Alzheimer's disease by targeting amyloid precursor protein.

  2015cited by this paper
• Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA‐195 down‐regulation

  2015cited by this paper
• Unique features of long non-coding RNA biogenesis and function

  2015influential reference
• Distinct Expression of Long Non-Coding RNAs in an Alzheimer's Disease Model

  2015influential reference
• MicroRNAs in cancer.

  2014cited by this paper
• Synaptic and Cognitive Improvements by Inhibition of 2-AG Metabolism Are through Upregulation of MicroRNA-188-3p in a Mouse Model of Alzheimer's Disease

  2014cited by this paper
• HuD regulates coding and noncoding RNA to induce APP→Aβ processing.

  2014cited by this paper
• Development of microRNA therapeutics is coming of age

  2014cited by this paper
• MicroRNA-125 b induced tau hyperphosphorylation and cognitive deficits in Alzheimer ' s Disease

  2014cited by this paper
• Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1-AS expression

  2014cited by this paper
• Non-coding RNA regulation of synaptic plasticity and memory: implications for aging.

  2014cited by this paper
• Detecting and characterizing circular RNAs

  2014cited by this paper
• The rise of regulatory RNA

  2014cited by this paper
• The γ-secretase complex: from structure to function

  2014cited by this paper
• A lentiviral sponge for miR-101 regulates RanBP9 expression and amyloid precursor protein metabolism in hippocampal neurons

  2014cited by this paper
• MicroRNA‐125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease

  2014cited by this paper
• The Role of SORL1 in Alzheimer’s Disease

  2014cited by this paper
• Epigenome-wide analysis of piRNAs in gene-specific DNA methylation

  2014cited by this paper
• MicroRNAs targeting Nicastrin regulate Aβ production and are affected by target site polymorphisms

  2014cited by this paper
• Natural RNA circles function as efficient microRNA sponges

  2013cited by this paper
• MicroRNA-339-5p Down-regulates Protein Expression of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 (BACE1) in Human Primary Brain Cultures and Is Reduced in Brain Tissue Specimens of Alzheimer Disease Subjects*

  2013cited by this paper
• Circular RNA (circRNA) in Alzheimer's disease (AD)

  2013cited by this paper
• Non-Coding RNAs: Multi-Tasking Molecules in the Cell

  2013cited by this paper
• Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.

  2013cited by this paper
• MicroRNA-144 Is Regulated by Activator Protein-1 (AP-1) and Decreases Expression of Alzheimer Disease-related A Disintegrin and Metalloprotease 10 (ADAM10)*

  2013cited by this paper
• Studying micro RNA Function and Dysfunction in Alzheimer’s Disease

  2013cited by this paper
• Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

  2013cited by this paper
• MicroRNA-195 Protects Against Dementia Induced by Chronic Brain Hypoperfusion via Its Anti-Amyloidogenic Effect in Rats

  2013cited by this paper
• Molecular functions of small regulatory noncoding RNA

  2013cited by this paper
• CD33 Alzheimer’s disease locus: Altered monocyte function and amyloid biology

  2013cited by this paper
• Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

  2013cited by this paper
• Alternative polyadenylation and miR‐34 family members regulate tau expression

  2013cited by this paper
• Posttranscriptional gene regulation by long noncoding RNA.

  2013cited by this paper
• MicroRNAs and neurodegeneration: role and impact.

  2013cited by this paper
• Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease

  2013cited by this paper

• Differentially expressed miRNAs in the temporal cortex of Alzheimer’s disease patients and their association to tau pathology

  2026cites this paper
• lncRNAs: key player in Aβ deposition.

  2026cites this paper
• Non-coding RNA-mediated gene regulation in Alzheimer's disease pathogenesis: molecular insights and emerging innovations

  2025cites this paper
• Whole Transcriptome RNA-Seq Reveals Drivers of Pathological Dysfunction in a Transgenic Model of Alzheimer’s Disease

  2025cites this paper
• Amyloid-β-Induced Neurotoxicity Modulates miR-98 and miR-200 Expression in SH-SY5Y Cells: A Step Toward Alzheimer’s Biomarker Discovery

  2025cites this paper
• A novel lncRNA FAM151B-DT regulates autophagy and degradation of aggregation prone proteins

  2025cites this paper
• Interleukin-12 signaling drives Alzheimer’s disease pathology through disrupting neuronal and oligodendrocyte homeostasis

  2025cites this paper
• Hallmarks of aging and Alzheimer's Disease pathogenesis: paving the route for new therapeutic targets.

  2025cites this paper
• Small noncoding RNAs: Pioneering a new therapeutic era in Alzheimer's disease.

  2025cites this paper
• Non-coding RNAs in the pathogenesis of Alzheimer’s disease: β-amyloid aggregation, Tau phosphorylation and neuroinflammation

  2025cites this paper
• Rewired m6A methylation of promoter antisense RNAs in Alzheimer’s disease regulates global gene transcription in the 3D nucleome

  2025cites this paper
• Celastrol treatment attenuates the inflammatory response in Alzheimer's disease model mice.

  2025cites this paper
• Pseudogene Lamr1-ps1 Aggravates Early Spatial Learning Memory Deficits in Alzheimer’s Disease Model Mice

  2025cites this paper
• Non-Coding RNAs: lncRNA, piRNA, and snoRNA as Robust Plasma Biomarkers of Alzheimer’s Disease

  2025cites this paper
• Rewired m6A of promoter antisense RNAs in Alzheimer’s disease regulates neuronal genes in 3D nucleome

  2025cites this paper
• Bidirectional Relationship between the BDNF Gene and miRNA: Implications for PD Pathogenesis.

  2025cites this paper
• Identification of the EBF1/ETS2/KLF2-miR-126-Gene Feed-Forward Loop in Breast Carcinogenesis and Stemness

  2025cites this paper
• Non-coding RNAs as key players in neurodegeneration and brain tumors: Insights into therapeutic strategies

  2025cites this paper
• Reduced UPF1 levels in senescence impair nonsense-mediated mRNA decay

  2025cites this paper
• Unveiling the Role of Novel miRNA PC-5P-12969 in Alleviating Alzheimer’s Disease

  2024cites this paper
• Alterations of mRNAs and Non-coding RNAs Associated with Neuroinflammation in Alzheimer’s Disease

  2024cites this paper
• The Role of Non-Coding RNAs in Mitochondrial Dysfunction of Alzheimer’s Disease

  2024cites this paper
• Downregulation of hsa-miR-132 and hsa-miR-129: non-coding RNA molecular signatures of Alzheimer’s disease

  2024cites this paper
• Effects and mechanisms of bisphenols exposure on neurodegenerative diseases risk: A systemic review.

  2024cites this paper
• Blood-based microRNAs as the potential biomarkers for Alzheimer’s disease: evidence from a systematic review

  2024cites this paper
• Harnessing the potential of long non-coding RNAs in the pathophysiology of Alzheimer's disease.

  2024cites this paper
• Optimizing gene selection for Alzheimer's disease classification: A Bayesian approach to filter and embedded techniques

  2024cites this paper
• Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s Disease

  2024cites this paper
• Exploring ncRNAs in epilepsy: From oxidative stress regulation to therapy.

  2024cites this paper
• Role of Epigenetic Modulation in Neurodegenerative Diseases: Implications of Phytochemical Interventions

  2024cites this paper
• The Association between Long Non-Coding RNAs and Alzheimer’s Disease

  2024influential citation
• The interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing

  2024cites this paper
• Entropy-driven catalysis-based lateral flow assay for sensitive detection of Alzheimer 's-associated MicroRNA.

  2024cites this paper
• Unravelling the complex interplay of cuproptosis, lncRNAs, and immune infiltration in Alzheimer’s disease: a step towards novel therapeutic targets

  2024cites this paper
• Exploring the molecular mechanisms of MSC-derived exosomes in Alzheimer's disease: Autophagy, insulin and the PI3K/Akt/mTOR signaling pathway.

  2024cites this paper
• Restoring the epigenome in Alzheimer's disease: Advancing HDAC inhibitors as therapeutic agents.

  2024cites this paper
• Therapeutic potential of adipose-derived stem cell extracellular vesicles: from inflammation regulation to tissue repair

  2024cites this paper
• Non-coding RNAs involved in the molecular pathology of Alzheimer’s disease: a systematic review

  2024cites this paper
• Integrative Analysis of the Age-Related Dysregulated Genes Reveals an Inflammation and Immunity-Associated Regulatory Network in Alzheimer’s Disease

  2024cites this paper
• Long Noncoding RNA NR_030777 Alleviates Cobalt Nanoparticles-Induced Neurodegenerative Damage by Promoting Autophagosome–Lysosome Fusion

  2024cites this paper
• Development of Computational Correlations among Known Drug Scaffolds and their Target-Specific Non-Coding RNA Scaffolds of Alzheimer's Disease.

  2023cites this paper
• Role of primary aging hallmarks in Alzheimer´s disease

  2023cites this paper
• Mitochondrial dysfunction following repeated administration of alprazolam causes attenuation of hippocampus-dependent memory consolidation in mice

  2023cites this paper
• Non-Coding RNA in Microglia Activation and Neuroinflammation in Alzheimer’s Disease

  2023cites this paper
• miR-429-3p mediates memory decline by targeting MKP-1 to reduce surface GluA1-containing AMPA receptors in a mouse model of Alzheimer's disease

  2023cites this paper
• Small RNA Profiles of Brain Tissue-Derived Extracellular Vesicles in Alzheimer’s Disease

  2023cites this paper
• Non-coding RNAs in Regulation of Protein Aggregation and Clearance Pathways: Current Perspectives Towards Alzheimer's Research and Therapy.

  2023cites this paper
• Neurodevelopmental toxicity induced by PM2.5 Exposure and its possible role in Neurodegenerative and mental disorders

  2023cites this paper
• An insight into structure-activity relationship of naturally derived biological macromolecules for the treatment of Alzheimer’s disease: a review

  2023cites this paper
• MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease

  2023cites this paper
• Therapeutic application of mesenchymal stem cells derived exosomes in neurodegenerative diseases: A focus on non-coding RNAs cargo, drug delivery potential, perspective.

  2023cites this paper
• Non-coding RNAs in Recurrent implantation failure.

  2023cites this paper
• Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer’s disease (AD): A systematic review and meta-analysis

  2023cites this paper
• Emerging role of non-coding RNAs in neuroinflammation mediated by microglia and astrocytes

  2023cites this paper
• Quadruple Cascade Strand Displacement Amplification Reaction Mediated Polyfluorene Derivative-Based Multiple FRET for Synchronous Determination of Multiple Biomarkers

  2023cites this paper
• MicroRNA Schizophrenia: Etiology, Biomarkers and Therapeutic Targets.

  2023cites this paper
• The regulatory role of non-coding RNAs and their interactions with phytochemicals in neurodegenerative diseases: a systematic review.

  2023cites this paper
• Alzheimer’s Disease-Related Epigenetic Changes: Novel Therapeutic Targets

  2023cites this paper
• Long RNA Profiles of Human Brain Extracellular Vesicles Provide New Insights into the Pathogenesis of Alzheimer’s Disease

  2023cites this paper
• Roles of lncRNAs in brain development and pathogenesis: Emerging therapeutic opportunities

  2023cites this paper
• Roles of Non-Coding RNA in Alzheimer’s Disease Pathophysiology

  2023cites this paper
• The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases.

  2023cites this paper
• Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)

  2022cites this paper
• Artificial Intelligence Predictor for Alzheimer’s Disease Trained on Blood Transcriptome: The Role of Oxidative Stress

  2022cites this paper
• Recent insights into the roles of circular RNAs in human brain development and neurologic diseases.

  2022cites this paper
• Noncoding RNAs: Novel Targets for Opioid Tolerance

  2022cites this paper
• Immune-related lncRNAs, LINC01268 and CTB-31O20.2, as favorable prognostic markers for glioma inhibition

  2022cites this paper
• Long non-coding RNA MALAT1 protects against Aβ1-42 induced toxicity by regulating the expression of receptor tyrosine kinase EPHA2 via quenching miR-200a/26a/26b in Alzheimer's disease.

  2022cites this paper
• Differentially expressed long noncoding RNAs and mRNAs in PC12 cells under lysophosphatidylcholine stimulation

  2022cites this paper
• The Involvement of lncRNA HOTAIR/miR-130a-3p Axis in the Regulation of Voluntary Exercise on Cognition and Inflammation of Alzheimer’s Disease

  2022cites this paper
• Hypoxic pretreatment of adipose-derived stem cell exosomes improved cognition by delivery of circ-Epc1 and shifting microglial M1/M2 polarization in an Alzheimer’s disease mice model

  2022cites this paper
• miR-200a-3p Regulates PRKACB and Participates in Aluminium-Induced Tau Phosphorylation in PC12 Cells

  2022cites this paper
• Transcriptome analysis of fasudil treatment in the APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer’s disease

  2022cites this paper
• MicroRNAs: protective regulators for neuron growth and development

  2022cites this paper
• Germline mutations directions are different between introns of the same gene: case study of the gene coding for amyloid-beta precursor protein

  2022cites this paper
• Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review

  2022cites this paper
• CapsNet-LDA: predicting lncRNA-disease associations using attention mechanism and capsule network based on multi-view data

  2022cites this paper
• A study of the prognostic value of long non-coding RNA CASC15 in human solid tumors utilizing The Cancer Genome Atlas (TCGA) datasets and a meta-analysis

  2022cites this paper
• Insights into the mechanisms of non-coding RNAs’ implication in the pathogenesis of Alzheimer’s disease

  2022cites this paper
• Aging and aging-related diseases: from molecular mechanisms to interventions and treatments

  2022cites this paper
• Differential expression of MicroRNAs in Alzheimer’s disease: a systematic review and meta-analysis

  2022cites this paper
• Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy

  2022cites this paper
• Identification of repurposed drugs targeting significant long non-coding RNAs in the cross-talk between diabetes mellitus and Alzheimer’s disease

  2022cites this paper
• The circRNA and Role in Alzheimer’s Disease: From Regulation to Therapeutic and Diagnostic Targets

  2022cites this paper
• Non-Coding RNAs in the Regulation of Hippocampal Neurogenesis and Potential Treatment Targets for Related Disorders

  2022cites this paper
• Profile of TREM2-Derived circRNA and mRNA Variants in the Entorhinal Cortex of Alzheimer’s Disease Patients

  2022cites this paper
• Non-coding RNAs: The Neuroinflammatory Regulators in Neurodegenerative Diseases

  2022cites this paper
• Screening of Human Circular RNAs as Biomarkers for Early Onset Detection of Alzheimer’s Disease

  2022cites this paper
• Bioinformatics Analysis of ceRNA Regulatory Network in Alzheimer’s Disease

  2022cites this paper
• Exploring the role of non-coding RNAs as potential candidate biomarkers in the cross-talk between diabetes mellitus and Alzheimer’s disease

  2022cites this paper
• Long noncoding RNA MAGI2-AS3 regulates the H2O2 level and cell senescence via HSPA8

  2022cites this paper
• Dynamic 3D DNA Rolling Walkers via Directional Movement on a Lipid Bilayer Supported by Au@Fe3O4 Nanoparticles for Sensitive Detection of MiRNA-16.

  2022cites this paper
• Prediction of RNA-interacting residues in a protein using CNN and evolutionary profile

  2022cites this paper
• LncRNA RMRP accelerates autophagy-mediated neurons apoptosis through miR-3142/TRIB3 signaling axis in Alzheimer's disease.

  2022cites this paper
• ZBTB20-AS1 promoted Alzheimer's disease progression through ZBTB20/GSK-3β/Tau pathway.

  2022cites this paper
• Hsa_circ_0063804 enhances ovarian cancer cells proliferation and resistance to cisplatin by targeting miR-1276/CLU axis

  2022cites this paper
• Circular RNAs in Alzheimer's Disease: A New Perspective of Diagnostic and Therapeutic Targets.

  2022cites this paper
• A method for simultaneous detection of small and long RNA biotypes by ribodepleted RNA-Seq

  2022cites this paper
• Long Non-Coding RNAs, Extracellular Vesicles and Inflammation in Alzheimer’s Disease

  2022cites this paper
• Long non-coding ribonucleic acid W5 inhibits progression and predicts favorable prognosis in hepatocellular carcinoma

  2021cites this paper